Clinical trial
Clinical Trial to Investigate Superiority of HLA Matching in Comparison to Random Graft Assignment With Respect to the Endpoint 'Time to First Endothelial Graft Rejection' in Penetrating Keratoplasty.
NCT00810472 is registered in ClinicalTrials.gov with University Hospital Freiburg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Trial to Investigate Superiority of HLA Matching in Comparison to Random Graft Assignment With Respect to the Endpoint 'Time to First Endothelial Graft Rejection' in Penetrating Keratoplasty.
- Lead sponsor
- University Hospital Freiburg
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2009
- Completion date
- May 31, 2015
- Enrollment
- 650 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.